Skip to main content
Journal cover image

Phase I trial of temozolomide plus dose-escalating imatinib mesylate for patients with malignant glioma

Publication ,  Conference
Sathornsumetee, S; Rich, JN; Vredenburgh, JJ; Desjardins, A; Quinn, JA; Gururangan, S; Friedman, AH; Egorin, MJ; Salvado, A; Friedman, HS; Reardon, DA
Published in: NEURO-ONCOLOGY
October 1, 2006

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

451 / 451

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sathornsumetee, S., Rich, J. N., Vredenburgh, J. J., Desjardins, A., Quinn, J. A., Gururangan, S., … Reardon, D. A. (2006). Phase I trial of temozolomide plus dose-escalating imatinib mesylate for patients with malignant glioma. In NEURO-ONCOLOGY (Vol. 8, pp. 451–451). Vienna, AUSTRIA: DUKE UNIV PRESS.
Sathornsumetee, Sith, Jeremy N. Rich, James J. Vredenburgh, Annick Desjardins, Jennifer A. Quinn, Sri Gururangan, Allan H. Friedman, et al. “Phase I trial of temozolomide plus dose-escalating imatinib mesylate for patients with malignant glioma.” In NEURO-ONCOLOGY, 8:451–451. DUKE UNIV PRESS, 2006.
Sathornsumetee S, Rich JN, Vredenburgh JJ, Desjardins A, Quinn JA, Gururangan S, et al. Phase I trial of temozolomide plus dose-escalating imatinib mesylate for patients with malignant glioma. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 451–451.
Sathornsumetee, Sith, et al. “Phase I trial of temozolomide plus dose-escalating imatinib mesylate for patients with malignant glioma.” NEURO-ONCOLOGY, vol. 8, no. 4, DUKE UNIV PRESS, 2006, pp. 451–451.
Sathornsumetee S, Rich JN, Vredenburgh JJ, Desjardins A, Quinn JA, Gururangan S, Friedman AH, Egorin MJ, Salvado A, Friedman HS, Reardon DA. Phase I trial of temozolomide plus dose-escalating imatinib mesylate for patients with malignant glioma. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 451–451.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

451 / 451

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences